BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 1569604)

  • 1. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma.
    Sameshima Y; Tsunematsu Y; Watanabe S; Tsukamoto T; Kawa-ha K; Hirata Y; Mizoguchi H; Sugimura T; Terada M; Yokota J
    J Natl Cancer Inst; 1992 May; 84(9):703-7. PubMed ID: 1569604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.
    Liu PK; Kraus E; Wu TA; Strong LC; Tainsky MA
    Oncogene; 1996 Jun; 12(11):2267-78. PubMed ID: 8649766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The evaluation of the possibility of Li-Fraumeni syndrome in cancer patients in East Azarbaijan Province of Iran.
    Esmaeilzadeh Aghjeh M; Hosseinpour Feizi MA; Safaralizadeh R; Hosseinpour Feizi AA; Pouladi N
    Nucleosides Nucleotides Nucleic Acids; 2024; 43(5):417-426. PubMed ID: 37801337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TP53, MSH4, and LATS1 germline mutations in a family with clustering of nervous system tumors.
    Kim YH; Ohta T; Oh JE; Le Calvez-Kelm F; McKay J; Voegele C; Durand G; Mittelbronn M; Kleihues P; Paulus W; Ohgaki H
    Am J Pathol; 2014 Sep; 184(9):2374-81. PubMed ID: 25041856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
    Malkin D; Li FP; Strong LC; Fraumeni JF; Nelson CE; Kim DH; Kassel J; Gryka MA; Bischoff FZ; Tainsky MA
    Science; 1990 Nov; 250(4985):1233-8. PubMed ID: 1978757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 protein.
    Frebourg T; Kassel J; Lam KT; Gryka MA; Barbier N; Andersen TI; Børresen AL; Friend SH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6413-7. PubMed ID: 1631137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics of Li-Fraumeni Syndrome in Japan; A Review Study by the Special Committee of JSHT.
    Funato M; Tsunematsu Y; Yamazaki F; Tamura C; Kumamoto T; Takagi M; Kato S; Sugimura H; Tamura K
    Cancer Sci; 2021 May; 112(7):2821-34. PubMed ID: 33932062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal incidentaloma and the Janus Kinase 2 V617F mutation: A case-based review of the literature.
    Unubol M; Guney E; Demirkol A; Yavasoglu I; Soyder A; Bozkurt G; Bolaman Z
    Indian J Endocrinol Metab; 2013 Jan; 17(1):153-6. PubMed ID: 23776870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rare and unusual endocrine cancer syndromes with mutated genes.
    Lodish MB; Stratakis CA
    Semin Oncol; 2010 Dec; 37(6):680-90. PubMed ID: 21167385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Childhood adrenocortical tumours: a review.
    Marques-Pereira R; Delacerda L; Lacerda HM; Michalkiewicz E; Sandrini F; Sandrini R
    Hered Cancer Clin Pract; 2006 May; 4(2):81-9. PubMed ID: 20223012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 Tetramerization domain mutations: germline R342X and R342P, and somatic R337G identified in pediatric patients with Li-Fraumeni syndrome and a child with adrenocortical carcinoma.
    Fiszer-Maliszewska L; Kazanowska B; Padzik J;
    Fam Cancer; 2009; 8(4):541-6. PubMed ID: 19714490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular pathology of adrenal cortical tumors: separating adenomas from carcinomas.
    Giordano TJ
    Endocr Pathol; 2006; 17(4):355-63. PubMed ID: 17525484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discerning malignancy in resected adrenocortical neoplasms.
    Sasano H; Suzuki T; Moriya T
    Endocr Pathol; 2001; 12(4):397-406. PubMed ID: 11914473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.
    Ribeiro RC; Sandrini F; Figueiredo B; Zambetti GP; Michalkiewicz E; Lafferty AR; DeLacerda L; Rabin M; Cadwell C; Sampaio G; Cat I; Stratakis CA; Sandrini R
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9330-5. PubMed ID: 11481490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of germline CHK2 mutations in familial gastric cancer.
    Kimura K; Shinmura K; Yoshimura K; Shimizu K; Katai H; Beppu Y; Moriya H; Yokota J
    Jpn J Cancer Res; 2000 Sep; 91(9):875-9. PubMed ID: 11011113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.
    Varley JM; McGown G; Thorncroft M; James LA; Margison GP; Forster G; Evans DG; Harris M; Kelsey AM; Birch JM
    Am J Hum Genet; 1999 Oct; 65(4):995-1006. PubMed ID: 10486318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous adrenocortical carcinoma and ganglioneuroblastoma in a child with Turner syndrome and germline p53 mutation.
    Pivnick EK; Furman WL; Velagaleti GV; Jenkins JJ; Chase NA; Ribeiro RC
    J Med Genet; 1998 Apr; 35(4):328-32. PubMed ID: 9598730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Li-Fraumeni syndrome--a molecular and clinical review.
    Varley JM; Evans DG; Birch JM
    Br J Cancer; 1997; 76(1):1-14. PubMed ID: 9218725
    [No Abstract]   [Full Text] [Related]  

  • 19. Tumors associated with p53 germline mutations: a synopsis of 91 families.
    Kleihues P; Schäuble B; zur Hausen A; Estève J; Ohgaki H
    Am J Pathol; 1997 Jan; 150(1):1-13. PubMed ID: 9006316
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.